申请人:Ly Tai Wei
公开号:US20110218207A1
公开(公告)日:2011-09-08
Provided herein are isotopically enriched arylsulfonamides, for example, of Formula I, that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
本文提供了同位素丰富的芳基磺酰胺,例如式I,它们对于调节CCR3活性是有用的,并且还提供了它们的制药组合物。本文还提供了使用这些化合物治疗、预防或改善CCR3介导的疾病、疾病或症状的方法。